SureTyper for HLA


Regulatory: CE-IVD: For In Vitro Diagnostic Use. (European Union Only)

Use: SureTyper for HLA is the software platform used with LinkSēq HLA, HPA, and KIR products for automated and simplified genotype reporting.

Customer Notice: Compatible with Windows® 10.0

SureTyper version 6.1 Key Features

SureTyper 6.1 contains an enhanced Tray Viewer and Well Viewer interface that allows users to visualize the reactivity of our new multi-targeted assays! Whether one target is positive, both targets are positive, or the assay is negative, the updated Tray Viewer and Well Viewer provides the user with visibility to the reactivity of this enhanced assay design.

A complete list of new features can be found in the respective Release Notes located in the Product Support Files section of this page.

Who should upgrade?
  • We strongly recommend all current SABR customers download SureTyper 6.1 in order to benefit from the highest resolution SABR kits. The latest enhanced resolution kits cannot be analyzed with SureTyper 5.0.
  • All other current LinkSēq HLA and KIR customers are also recommended to upgrade for user experience enhancements

Who should not upgrade?
  • LinkSēq HPA customers should retain SureTyper 5.0 until the launch of SureTyper Blood (supporting HPA and ABO), as SureTyper 6.0 does not include support for HPA kits.
  • Customers can run SureTyper 5.0 and SureTyper 6.1 simultaneously on their computers